MANGOCEUTICALS INC (MGRX) Stock Overview
USA - NASDAQ:MGRX - US56270V2051 - Common Stock
MGRX Key Statistics, Chart & Performance
The current stock price of MGRX is 2.07 USD. In the past month the price increased by 1.42%. In the past year, price decreased by -5.31%.
MGRX Latest News, Press Relases and Analysis
MGRX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| GRDN | GUARDIAN PHRMCY SERVICES-A | N/A | 1.87B | ||
| YI | 111 INC | N/A | 38.21M | ||
| RDGT | RIDGETECH INC | 0.85 | 8.79M | ||
| SRXH | SRX HEALTH SOLUTIONS INC | N/A | 9.19M |
Related stock screener links
About MGRX
Company Profile
Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. The company has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
Company Info
MANGOCEUTICALS INC
15110 Dallas Pkwy, Suite 600
Dallas TEXAS US
Employees: 3
Phone: 18336264679
MANGOCEUTICALS INC / MGRX FAQ
What does MGRX do?
Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. The company has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
What is the current price of MGRX stock?
The current stock price of MGRX is 2.07 USD. The price decreased by -3.27% in the last trading session.
Does MGRX stock pay dividends?
MGRX does not pay a dividend.
What is the ChartMill technical and fundamental rating of MGRX stock?
MGRX has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the PE ratio for MGRX stock?
MANGOCEUTICALS INC (MGRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.33).
Can you provide the market cap for MANGOCEUTICALS INC?
MANGOCEUTICALS INC (MGRX) has a market capitalization of 21.82M USD. This makes MGRX a Nano Cap stock.
MGRX Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to MGRX. When comparing the yearly performance of all stocks, MGRX turns out to be only a medium performer in the overall market: it outperformed 60.95% of all stocks.
MGRX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to MGRX. MGRX may be in some trouble as it scores bad on both profitability and health.
MGRX Financial Highlights
Over the last trailing twelve months MGRX reported a non-GAAP Earnings per Share(EPS) of -3.33. The EPS increased by 33.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -68.14% | ||
| ROE | -73.81% | ||
| Debt/Equity | 0.03 |